Compatibility and efficacy of a skincare regimen with a single IPL treatment
Hanh Pham, MS, Mary Kay, Inc., Addison, TX, United States; James Leyden, MD, University of Pennsylvania, Philadelphia, PA, United States; Alphonsus Dang, PhD, Mary Kay, Inc., Addison, TX, United States; Brian Jones, PhD, Mary Kay,
Inc., Addison, TX, United States
Intense pulsed light (IPL) treatment is a dermatologic procedure often used to reduce facial spider veins, tighten skin, reduce wrinkling, facial hair, and for addressing skin pigmentary problems associated with red or brown color. IPL acts by delivering filtered, multi-spectral light to target chromophores in the skin.
Typically, a series of 3 to 5 treatments are necessary to achieve desired results.
The aim of this 12-week clinical study was to evaluate the compatibility and efficacy of a skincare regimen when used in conjunction with a single treatment of IPL. A doubleblind, randomized, vehicle-controlled study was conducted consisting of 36 subjects applying the skincare product regimen daily and a control group consisting of 25 subjects utilizing a vehicle control product twice daily.
At baseline, all subjects underwent an IPL treatment. Dermal compatibility assessments for erythema, scaling/peeling, edema, burning/stinging and itching were evaluated at baseline and weeks 1, 4, 8, and 12. Additionally, expert-grader visual assessments were conducted by a dermatologist at baseline and at weeks 4, 8, and 12 for the following attributes:
even skin tone, discreet pigment, mottled pigment, blotchy erythema, persistent erythema, fine wrinkles, coarse wrinkle, and overall photodamage. Further, color photographs were taken at baseline and week 12. The results demonstrate the use of the facial skin care regimen was compatible with an IPL treatment and provided
continued, significant improvement of all visual test attributes and all time points measured after a single IPL treatment.
**taken from http://www.aad.org/meetings/previous/_doc/Posters_2007%20Annual%20Meeting.pdf, accessed on 28/04/09**


0